Seven patients affected by bilateral inflammatory serpiginous choroiditis have been treated with Cyclosporine-A for 6-21 months. Nine outof the fourteen eyes showed a significant improvement in their visual acuity; five eyes did not change.
Cyclosporine-A may, therefore, be considered effective in the treatment of this disease.
Its usefulness seems to be greater when the serpiginous choroiditis is in its
acute
stage;
chronic
stages, however, also seem to improve under treatment.
Its main indication is, in our opinion, the involvement of the macular region of the
second
eye, when the
first
eye is already damaged. We consider Cyclosporine-A, in these situations, to be a first choice treatment.
Key words Serpiginous choroiditis - geographic choroidopathy - Cyclosporine-A in uveitis - immunosuppression in uveitis